Baylor Research Institute has been awarded a $3.3 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for its Autoimmunity Center of Excellence, which led by Virginia Pascual.
The grant was attributed to Dr. Pascual’s Research in autoimmune diseases, like lupus, dermatomyositis and juvenile arthritis. This last disease, according to the president of Baylor Research Institute, Michael Ramsay, MD, has proven to be of major importance. “Her work on juvenile arthritis led to a successful treatment for children who did not respond to other therapies.” Plus, the recognition of the researcher’s work “demonstrates the quality and success of our program,” Ramsay said.
To Dr. Pascual, also director at Baylor Institute for Immunology Research (BIIR), and whose “goals include understanding the mechanisms that lead to autoimmunity and developing tools to monitor these dysfunctional pathways in patients,” it was a fortune to see this fund renewed.
This isn’t the first time Virginia Pascual has received grants from the National Institutes of Health. In 2009 NIAMS granted her with 3.5 million, which allowed her to launch the BIIR Autoimmunity Center of Excellence, a distinction only given to “outstanding” centers. In 2006, NIAMS also granted her $6.2 million dollars for research into Lupus.
Baylor Research Institute (BRI) is a scientific and medical research center focused on diseases and their treatment. Baylor Institute for Immunology Research (BIIR) works on one specific area of this major group, immunology, with the goal of preventing before diseases happen.
In order to understand the basis of a disease, BRI develops its work in a proximity philosophy with the patients, engaging them in research trials.
Baylor Research Institute is supported by grants from National Institutes of Health, such as NIAMS, and by other national organizations.